Zhang BB - Search Results

1

Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.

Jiang G, Dallas-Yang Q, Li Z, Szalkowski D, Liu F, Shen X, Wu M, Zhou G, Doebber T, Berger J, Moller DE, Zhang BB. Jiang G, et al. Among authors: zhang bb. Diabetes. 2002 Aug;51(8):2412-9. doi: 10.2337/diabetes.51.8.2412. Diabetes. 2002. PMID: 12145152

2

Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.

Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu M, Sachs JR, Bagchi A, Fridman A, Holder DJ, Doebber TW, Berger J, Elbrecht A, Moller DE, Zhang BB. Gerhold DL, et al. Among authors: zhang bb. Endocrinology. 2002 Jun;143(6):2106-18. doi: 10.1210/endo.143.6.8842. Endocrinology. 2002. PMID: 12021175

3

Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells.

Jiang G, Dallas-Yang Q, Liu F, Moller DE, Zhang BB. Jiang G, et al. Among authors: zhang bb. J Biol Chem. 2003 Jan 3;278(1):180-6. doi: 10.1074/jbc.M205565200. Epub 2002 Oct 29. J Biol Chem. 2003. PMID: 12409308 Free article.

4

Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.

Jiang G, Dallas-Yang Q, Biswas S, Li Z, Zhang BB. Jiang G, et al. Among authors: zhang bb. Biochem J. 2004 Jan 15;377(Pt 2):339-46. doi: 10.1042/BJ20031207. Biochem J. 2004. PMID: 14556646 Free PMC article.

5

A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.

Qureshi SA, Rios Candelore M, Xie D, Yang X, Tota LM, Ding VD, Li Z, Bansal A, Miller C, Cohen SM, Jiang G, Brady E, Saperstein R, Duffy JL, Tata JR, Chapman KT, Moller DE, Zhang BB. Qureshi SA, et al. Among authors: zhang bb. Diabetes. 2004 Dec;53(12):3267-73. doi: 10.2337/diabetes.53.12.3267. Diabetes. 2004. PMID: 15561959

6

New approaches in the treatment of type 2 diabetes.

Zhang BB, Moller DE. Zhang BB, et al. Curr Opin Chem Biol. 2000 Aug;4(4):461-7. doi: 10.1016/s1367-5931(00)00103-4. Curr Opin Chem Biol. 2000. PMID: 10959776 Review.

7

Modulation of insulin signalling by insulin sensitizers.

Jiang G, Zhang BB. Jiang G, et al. Among authors: zhang bb. Biochem Soc Trans. 2005 Apr;33(Pt 2):358-61. doi: 10.1042/BST0330358. Biochem Soc Trans. 2005. PMID: 15787606 Review.

8

Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes.

Jiang G, Zhang BB. Jiang G, et al. Among authors: zhang bb. Front Biosci. 2002 Apr 1;7:d903-7. doi: 10.2741/A820. Front Biosci. 2002. PMID: 11897556 Review.

9

Regulation of insulin signal transduction pathway by a small-molecule insulin receptor activator.

Ding VD, Qureshi SA, Szalkowski D, Li Z, Biazzo-Ashnault DE, Xie D, Liu K, Jones AB, Moller DE, Zhang BB. Ding VD, et al. Among authors: zhang bb. Biochem J. 2002 Oct 1;367(Pt 1):301-6. doi: 10.1042/BJ20020708. Biochem J. 2002. PMID: 12036431 Free PMC article.

10

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.

Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, Elbrecht A, Johnson BA, Zhou G, Doebber TW, Biswas C, Parikh M, Sharma N, Tanen MR, Thompson GM, Ventre J, Adams AD, Mosley R, Surwit RS, Moller DE. Berger JP, et al. Among authors: zhang bb. Mol Endocrinol. 2003 Apr;17(4):662-76. doi: 10.1210/me.2002-0217. Epub 2003 Jan 16. Mol Endocrinol. 2003. PMID: 12554792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

469 results

Search Page